APT Medical Inc. (SHA:688617)

Market Cap	43.39B
Revenue (ttm)	2.28B
Net Income (ttm)	755.75M
Shares Out	141.01M
EPS (ttm)	5.35
PE Ratio	57.49
Forward PE	44.97
Dividend	1.21 (0.39%)
Ex-Dividend Date	Jun 19, 2025

Volume	950,260
Average Volume	1,003,118
Open	309.00
Previous Close	308.07
Day's Range	307.29 - 312.78
52-Week Range	225.60 - 324.77
Beta	-0.26
RSI	50.54
Earnings Date	Oct 24, 2025

About APT Medical

APT Medical Inc. engages in the research and development, production, and sale of cardiovascular interventional medical devices in China. The company offers electrophysiology products, such as mapping, ablation, and navigated catheter, as well as steerable, and transseptal needle and sheet; and interventional cardiology and peripheral products, including access, diagnostic, therapeutic, and accessories. It also provides OEM/ODM service comprising project design and development, customization, and volume OEM for use in catheters, guidewires, del...

• Industry: Medical Devices
• Sector: Healthcare
• Founded: 2002
• Employees: 2,555
• Stock Exchange: Shanghai Stock Exchange
• Ticker Symbol: 688617

Financial Performance

In 2024, APT Medical's revenue was 2.07 billion, an increase of 25.18% compared to the previous year's 1.65 billion. Earnings were 673.15 million, an increase of 26.08%.